U.S. Worries About 'Dangerous' Foreign Drugs, Not Its Own Exported Cluster Bombs
"Reliance on dangerous foreign generic drugs is killing Americans," proclaims The Hill, focusing on the vulnerability of our healthcare supply chain. Specifically, the article raises concerns about quality control for drugs like heparin, a crucial anticoagulant. This narrative conveniently diverts attention from the U.S. government's own role in supplying 'dangerous' foreign-made products to
others. While we might fret over contaminated medicine from abroad, perhaps we should spare a thought for the cluster munitions the Biden administration greenlit for transfer to Ukraine in July 2023, or the consistent flow of advanced weaponry to Israel, irrespective of its operations in Gaza. One might wonder if the concern for 'killing Americans' extends to the global impact of U.S.-sourced
military hardware. How many critical drug shortages does it take to equal the moral bankruptcy of arming conflicts that decimate civilian populations abroad? The Hill seems to possess a finely tuned sense of economic nationalism, but a rather selective memory regarding humanitarian impact.